Dr. Ilias Spanakis, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
827 Linden Ave
Baltimore, MD 21201
Who else practices at this address →
Baltimore city includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 27
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 84
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
MD license D74858 -
Internal Medicine Physician
MA license 237477
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Maryland Medical Center Baltimore, MD
- University of MD St Joseph Medical Center Towson, MD
Medical groups
- University of Maryland Physicians PA (404 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 84
- Services billed
- 210
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 41 | 19 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 23 | 23 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 3 companies. The companies reported $179,148 in research payments for these studies, mostly to the institutions running them.
- Innovative Automated Insulin Delivery System for Type 2 Diabetes
Sequel Med Tech, LLC · Completed · NCT06853990 - Effectiveness and safety of the dexcom G6 continuous glucose monitoring system in non-critically ill patients in the inpatient setting (hospital ysi)
Dexcom, Inc. - Investigator Sponsored Research: ONIT-39565599
Medtronic, Inc. - Investigator Sponsored Research: 190599
Medtronic, Inc. - Investigator Sponsored Research: 190598
Medtronic, Inc. - Investigator Sponsored Research: 190597
Medtronic, Inc. - Continuous glucose monitoring in insulin treated patients with DM2 at higher risk for hypoglycemia, a randomized clinical trial
Dexcom, Inc. - Investigator Sponsored Research: 190600
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.